Skip to content
Disclosery

BRAIDWELL LP

Follow

13F filer, CIK 1920938, STAMFORD, CT

BRAIDWELL LP reported $3,370,348,920 across 73 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 44.1% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-003410

Period
2025-09-30
Reported value
$3.37B
Holdings
73
Top 10 weight
44.1%
New
25
Sold out
7

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SLNOnew+1,281,989$86.7M
ACADnew+2,378,655$50.8M
HNGEnew+910,476$44.7M
CVSnew+438,600$33.1M
DNTHnew+835,057$32.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ARGXreduced-118,400-$87.3M
ADPTreduced-3,127,093-$46.8M
GHexited-837,800-$43.6M
NBIXreduced-280,143-$39.3M
KRYSreduced-207,410-$36.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001420506-25-003410, largest first. % of portfolio is the value over $3,370,348,920, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,316,142 shares; 2025Q3: 7,316,142 shares 7,316,142$221M6.57%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,707,255 shares; 2024Q4: 2,913,964 shares; 2025Q1: 2,709,875 shares; 2025Q2: 3,605,029 shares; 2025Q3: 3,605,029 shares 3,605,029$145M4.29%0Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,170,875 shares; 2024Q4: 3,283,317 shares; 2025Q1: 3,283,317 shares; 2025Q2: 3,283,317 shares; 2025Q3: 3,283,317 shares 3,283,317$132M3.92%0Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 917,674 shares; 2024Q4: 901,790 shares; 2025Q1: 1,191,925 shares; 2025Q2: 1,160,425 shares; 2025Q3: 880,282 shares 880,282$124M3.67%-280,143Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 168,691 shares; 2024Q4: 200,500 shares; 2025Q1: 400,744 shares; 2025Q2: 727,811 shares; 2025Q3: 520,401 shares 520,401$91.9M2.73%-207,410Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 241,235 shares; 2025Q1: 840,945 shares; 2025Q2: 1,175,876 shares; 2025Q3: 1,012,982 shares 1,012,982$87.6M2.6%-162,894Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,281,989 shares 1,281,989$86.7M2.57%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,958,310 shares; 2024Q4: 2,332,196 shares; 2025Q1: 2,458,808 shares; 2025Q2: 5,210,831 shares; 2025Q3: 5,210,831 shares 5,210,831$84.5M2.51%0Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 238,911 shares; 2024Q4: 293,410 shares; 2025Q1: 302,410 shares; 2025Q2: 522,410 shares; 2025Q3: 883,747 shares 883,747$65.6M1.95%+361,337Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 311,616 shares; 2024Q4: 288,876 shares; 2025Q1: 624,435 shares; 2025Q2: 603,414 shares; 2025Q3: 780,164 shares 780,164$63.6M1.89%+176,750Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 309,339 shares; 2025Q2: 309,339 shares; 2025Q3: 309,339 shares 309,339$61.3M1.82%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,541,551 shares; 2024Q4: 2,977,951 shares; 2025Q1: 2,977,951 shares; 2025Q2: 2,542,104 shares; 2025Q3: 1,826,155 shares 1,826,155$59.6M1.77%-715,949Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 91,300 shares; 2024Q4: 75,300 shares; 2025Q1: 88,000 shares; 2025Q2: 89,600 shares; 2025Q3: 130,227 shares 130,227$58.2M1.73%+40,627Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,643,226 shares; 2024Q4: 1,540,362 shares; 2025Q1: 1,540,362 shares; 2025Q2: 1,478,512 shares; 2025Q3: 1,438,745 shares 1,438,745$57.2M1.7%-39,767Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 96,724 shares; 2024Q4: 80,766 shares; 2025Q1: 160,849 shares; 2025Q2: 194,491 shares; 2025Q3: 76,091 shares 76,091$56.1M1.67%-118,400Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 89,754 shares; 2025Q1: 127,733 shares; 2025Q2: 135,233 shares; 2025Q3: 113,933 shares 113,933$55.3M1.64%-21,300Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 311,679 shares; 2024Q4: 375,179 shares; 2025Q1: 530,530 shares; 2025Q2: 496,730 shares; 2025Q3: 409,691 shares 409,691$51.3M1.52%-87,039Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,378,655 shares 2,378,655$50.8M1.51%newTimeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 910,476 shares 910,476$44.7M1.33%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,189,836 shares; 2024Q4: 2,578,404 shares; 2025Q1: 2,578,404 shares; 2025Q2: 2,578,404 shares; 2025Q3: 2,578,404 shares 2,578,404$43.2M1.28%0Timeline
TMDXTRANSMEDICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 922,100 shares; 2025Q1: 854,884 shares; 2025Q2: 255,048 shares; 2025Q3: 351,248 shares 351,248$39.4M1.17%+96,200Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 782,557 shares; 2024Q4: 705,391 shares; 2025Q1: 556,391 shares; 2025Q2: 300,029 shares; 2025Q3: 225,845 shares 225,845$38.8M1.15%-74,184Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 361,428 shares; 2024Q4: 183,828 shares; 2025Q1: 110,128 shares; 2025Q2: 129,628 shares; 2025Q3: 141,528 shares 141,528$35.9M1.06%+11,900Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 681,182 shares; 2025Q1: 3,621,344 shares; 2025Q2: 3,273,349 shares; 2025Q3: 2,730,481 shares 2,730,481$34.5M1.02%-542,868Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 438,600 shares 438,600$33.1M0.98%newTimeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 493,687 shares; 2024Q4: 1,206,589 shares; 2025Q1: 375,355 shares; 2025Q2: not reported; 2025Q3: 835,057 shares 835,057$32.9M0.97%newTimeline
CDNACAREDX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,182,781 shares 2,182,781$31.7M0.94%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 528,000 shares 528,000$28.6M0.85%newTimeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 247,200 shares; 2025Q3: 498,000 shares 498,000$28.5M0.85%+250,800Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 515,726 shares; 2024Q4: 1,147,676 shares; 2025Q1: 1,572,426 shares; 2025Q2: 1,524,842 shares; 2025Q3: 1,382,350 shares 1,382,350$26.6M0.79%-142,492Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 396,781 shares; 2024Q4: 283,823 shares; 2025Q1: 81,656 shares; 2025Q2: 144,556 shares; 2025Q3: 195,656 shares 195,656$26.2M0.78%+51,100Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,894,513 shares; 2024Q4: 3,452,447 shares; 2025Q1: 1,962,909 shares; 2025Q2: 1,102,580 shares; 2025Q3: 643,180 shares 643,180$25M0.74%-459,400Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 121,700 shares 121,700$24.7M0.73%newTimeline
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,353,287 shares; 2024Q4: 8,353,287 shares; 2025Q1: 8,353,287 shares; 2025Q2: 8,353,287 shares; 2025Q3: 8,353,287 shares 8,353,287$24M0.71%0Timeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 286,178 shares; 2024Q4: 353,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 414,600 shares 414,600$22.7M0.67%newTimeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 475,400 shares 475,400$22.6M0.67%newTimeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,041,065 shares; 2024Q4: 4,256,490 shares; 2025Q1: 4,259,429 shares; 2025Q2: 3,635,172 shares; 2025Q3: 1,514,604 shares 1,514,604$22M0.65%-2,120,568Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,107,770 shares; 2024Q4: 1,107,770 shares; 2025Q1: 1,107,770 shares; 2025Q2: 1,107,770 shares; 2025Q3: 1,107,770 shares 1,107,770$20.5M0.61%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,156,977 shares; 2024Q4: 1,479,666 shares; 2025Q1: 1,435,955 shares; 2025Q2: 1,437,555 shares; 2025Q3: 759,455 shares 759,455$20M0.59%-678,100Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 331,986 shares; 2024Q4: not reported; 2025Q1: 365,247 shares; 2025Q2: 822,735 shares; 2025Q3: 822,735 shares 822,735$18.7M0.56%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 303,685 shares 303,685$18.4M0.55%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 588,700 shares 588,700$17.7M0.53%newTimeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 439,638 shares; 2024Q4: 907,039 shares; 2025Q1: 956,839 shares; 2025Q2: 872,246 shares; 2025Q3: 342,391 shares 342,391$16.5M0.49%-529,855Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 370,400 shares; 2024Q4: 364,900 shares; 2025Q1: 234,500 shares; 2025Q2: not reported; 2025Q3: 832,100 shares 832,100$16M0.48%newTimeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 276,692 shares 276,692$15.7M0.46%newTimeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,266,319 shares 2,266,319$15.5M0.46%newTimeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,873,853 shares; 2024Q4: 4,873,853 shares; 2025Q1: 3,536,853 shares; 2025Q2: 2,181,598 shares; 2025Q3: 2,181,598 shares 2,181,598$15.4M0.46%0Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 591,689 shares 591,689$15.3M0.45%newTimeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 466,448 shares; 2024Q4: 615,531 shares; 2025Q1: 1,655,690 shares; 2025Q2: 1,655,690 shares; 2025Q3: 1,246,280 shares 1,246,280$14.6M0.43%-409,410Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 331,907 shares 331,907$14.5M0.43%newTimeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 113,335 shares 113,335$14.4M0.43%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 472,739 shares 472,739$13.7M0.41%newTimeline
NEONEOGENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,771,146 shares 1,771,146$13.7M0.41%newTimeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 736,867 shares 736,867$11.6M0.34%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,070,837 shares; 2024Q4: 1,477,102 shares; 2025Q1: 1,461,826 shares; 2025Q2: 422,887 shares; 2025Q3: 2,750,092 shares 2,750,092$11.5M0.34%+2,327,205Timeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,803,794 shares; 2025Q2: 3,863,107 shares; 2025Q3: 736,014 shares 736,014$11M0.33%-3,127,093Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,472,806 shares; 2024Q4: 2,472,806 shares; 2025Q1: 2,472,806 shares; 2025Q2: 2,472,806 shares; 2025Q3: 2,472,806 shares 2,472,806$10.7M0.32%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,081,855 shares; 2025Q3: 314,013 shares 314,013$9.24M0.27%-767,842Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 612,841 shares 612,841$8.33M0.25%newTimeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,068 shares 182,068$6.42M0.19%newTimeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,069,158 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 219,488 shares 219,488$2.02M0.06%newTimeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 140,000 shares 140,000$1.8M0.05%0Timeline
HTFLHEARTFLOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$1.68M0.05%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 752,541 shares; 2024Q4: 752,541 shares; 2025Q1: 752,541 shares; 2025Q2: 752,541 shares; 2025Q3: 752,541 shares 752,541$1.22M0.04%0Timeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
GUARDANT HEALTH INCGUARDANT HEALTH INC DEBT 1.250% 2/1principal219,454,000$286M0
NOVOCURE LTDNOVOCURE LTD NOTE 11/0principal211,364,000$210M+70,530,000
REPLIGEN CORPREPLIGEN CORP NOTE 1.000%12/1principal101,000,000$102M0
NEOGENOMICS INCNEOGENOMICS INC NOTE 0.250% 1/1principal100,381,000$86.8M-1,000,000
IRHYTHM HOLDINGS INCIRHYTHM HOLDINGS INC NOTE 1.500% 9/0principal62,000,000$85.4M-8,000,000
IRONWOOD PHARMACEUTICALS INCIRONWOOD PHARMACEUTICALS INC NOTE 1.500% 6/1principal82,140,000$72.9M-10,600,000
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC NOTE 6.000% 5/1principal48,482,000$35M0
DEXCOM INCDEXCOM INC NOTE 0.250%11/1principal13,500,000$13.4M-5,000,000
IMMUNOCORE HLDGS PLCIMMUNOCORE HLDGS PLC NOTE 2.500% 2/0principal6,828,000$6.19M-20,000,000

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GHGUARDANT HEALTH INC837,800$43.6Mshares
APLSAPELLIS PHARMACEUTICALS INC1,121,034$19.4Mshares
MDGLMADRIGAL PHARMACEUTICALS INC60,781$18.4Mshares
UNHUNITEDHEALTH GROUP INC49,400$15.4Mshares
CELCCELCUITY INC884,306$11.8Mshares
ALPHATEC HLDGS INCALPHATEC HLDGS INC5,818,000$5.77Mprincipal
CBIOCRESCENT BIOPHARMA INC.261,504$4.22Mshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-003410 base2025-11-14acceptance time not in the bulk data set